The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites

Minkyu Jung, Hei Cheul Jeung, Sung Sook Lee, Jun Yong Park, Soojung Hong, Soo Hyeon Lee, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Background: This study was carried out to evaluate the clinical significance of ascitic fluid carcinoembryonic antigen (CEA) in advanced gastric cancer patients with ascites. Patients and methods: From November 2001 to February 2008, 119 gastric cancer patients with concurrent ascites who were clinically diagnosed with carcinomatosis, were retrospectively reviewed with regard to ascitic fluid cytology and clinicopathological parameters. Serum CEA (sCEA) and ascitic fluid CEA (aCEA) were measured using a chemiluminescent enzyme immunoassay. Results: The patients' median age was 50 years (range 23-80 years). The median value of aCEA was significantly higher than sCEA [130.5 ng/ml (range 0.2-12.211 ng/ml) vs. 2.1 ng/ml (range 0.02-8.152 ng/ml), p < 0.001]. Sixty-five patients (54.6%) had positive ascitic fluid cytology. The median overall survival of all patients was 3.0 months (95% CI 2.0-4.0 months). The patients with low aCEA (<5 ng/ml) had a significantly longer overall survival compared to patients with high aCEA (≥5 ng/ml) (7.4 months vs. 2.3 months, p = 0.003). However, we found no difference in overall survival according to ascitic fluid cytology (median, 3.0 months vs. 2.5 months, p = 0.530). Multivariate analysis also demonstrated that aCEA levels of more than 5 ng/ml were associated with poor prognosis (HR = 2.88; 95% CI 1.45-5.74; p = 0.003), while sCEA levels were not associated with poor prognosis (HR = 1.15; 95% CI 0.67-2.03; p = 0.622). Conclusion: These results suggest that aCEA levels can be used as a prognostic marker for advanced gastric cancer patients with ascites.

Original languageEnglish
Pages (from-to)517-526
Number of pages10
JournalJournal of cancer research and clinical oncology
Volume136
Issue number4
DOIs
Publication statusPublished - 2010 Apr

Bibliographical note

Funding Information:
Acknowledgment This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MOST) (R11-2000-082-03006-0).

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites'. Together they form a unique fingerprint.

Cite this